ConductScience.org, home

Paper35199552

Coenzyme Q10 effects in neurological diseases.

Rauchová H. Physiol Res, 2021. Cited by 48 papers, by iCite.

Cite this record

ConductScience Library. Coenzyme Q10 effects in neurological diseases. Papers, record 35199552. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35199552

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Coenzyme Q10 effects in neurological diseases.
PubMed
Journal
Physiol Res
PubMed
Year
2021
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
48
iCite
Relative citation ratio, by iCite
3.62
iCite
Revised in PubMed
2022-07-16
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rauchová HH

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Mitochondrial DiseasesMajor topic
Nervous System DiseasesMajor topic
Animals
Antioxidants
Electron Transport
Humans
Mitochondria
Ubiquinone

Source PubMed

Download CSV of topics

References259

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110465173Effect of idebenone on cardiomyopathy in Friedreich's ataxia: a preliminary study.Lancet1999https://conductscience.org/library/papers/10465173PubMed
226311408Vascular dysfunction in the pathogenesis of Alzheimer's disease--A review of endothelium-mediated mechanisms and ensuing vicious circles.Neurobiol Dis2015https://conductscience.org/library/papers/26311408PubMed
38660670The interaction of Q analogs, particularly hydroxydecyl benzoquinone (idebenone), with the respiratory complexes of heart mitochondria.Arch Biochem Biophys1996https://conductscience.org/library/papers/8660670PubMed
416551570Coenzyme Q10: absorption, tissue uptake, metabolism and pharmacokinetics.Free Radic Res2006https://conductscience.org/library/papers/16551570PubMed
523859348Co-enzyme Q10 and idebenone use in Friedreich's ataxia.J Neurochem2013https://conductscience.org/library/papers/23859348PubMed
633245472Coenzyme Q10 enhances remyelination and regulate inflammation effects of cuprizone in corpus callosum of chronic model of multiple sclerosis.J Mol Histol2021https://conductscience.org/library/papers/33245472PubMed
74087945Tissue coenzyme Q (ubiquinone) and protein concentrations over the life span of the laboratory rat.Mech Ageing Dev1985https://conductscience.org/library/papers/4087945PubMed
815117836Increased reactive oxygen species in rostral ventrolateral medulla contribute to neural mechanisms of hypertension in stroke-prone spontaneously hypertensive rats.Circulation2004https://conductscience.org/library/papers/15117836PubMed
931707234The effect of emerging nutraceutical interventions for clinical and biological outcomes in multiple sclerosis: A systematic review.Mult Scler Relat Disord2020https://conductscience.org/library/papers/31707234PubMed
1028933272Evaluation of Metabolic and Synaptic Dysfunction Hypotheses of Alzheimer's Disease (AD): A Meta-Analysis of CSF Markers.Curr Alzheimer Res2018https://conductscience.org/library/papers/28933272PubMed
1120424336Oxidative stress and central cardiovascular regulation. - Pathogenesis of hypertension and therapeutic aspects -.Circ J2010https://conductscience.org/library/papers/20424336PubMed
1216400613A mutation in para-hydroxybenzoate-polyprenyl transferase (COQ2) causes primary coenzyme Q10 deficiency.Am J Hum Genet2006https://conductscience.org/library/papers/16400613PubMed
1310847562Serum levels of coenzyme Q10 in patients with Alzheimer's disease.J Neural Transm (Vienna)2000https://conductscience.org/library/papers/10847562PubMed
1418181031Coenzyme Q10 attenuates beta-amyloid pathology in the aged transgenic mice with Alzheimer presenilin 1 mutation.J Mol Neurosci2008https://conductscience.org/library/papers/18181031PubMed
1518560133Evaluation of coenzyme Q as an antioxidant strategy for Alzheimer's disease.J Alzheimers Dis2008https://conductscience.org/library/papers/18560133PubMed
1624483602Orally delivered water soluble Coenzyme Q10 (Ubisol-Q10) blocks on-going neurodegeneration in rats exposed to paraquat: potential for therapeutic application in Parkinson's disease.BMC Neurosci2014https://conductscience.org/library/papers/24483602PubMed
1710668462Coenzyme Q10 can in some circumstances block apoptosis, and this effect is mediated through mitochondria.Ann N Y Acad Sci1999https://conductscience.org/library/papers/10668462PubMed
182928337Muscle coenzyme Q deficiency in familial mitochondrial encephalomyopathy.Proc Natl Acad Sci U S A1989https://conductscience.org/library/papers/2928337PubMed
1917401348Protocol for the MPTP mouse model of Parkinson's disease.Nat Protoc2007https://conductscience.org/library/papers/17401348PubMed
209244403Steady-state kinetics of reduction of coenzyme Q analogs by glycerol-3-phosphate dehydrogenase in brown adipose tissue mitochondria.Arch Biochem Biophys1997https://conductscience.org/library/papers/9244403PubMed

See all 259 referencesDownload CSV of references

Cited by36

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 48 citations.

PMIDTitleJournalYearIn PapersSource
42967168The "Invisible Killer" of Neurodegeneration: Mitochondrial Dysfunction in Neurodegenerative Disorders, Mechanisms, Emerging Pathways and Therapeutic Strategies.J Inflamm Res2026https://conductscience.org/library/papers/42967168PubMed
42794580Statins and Myasthenia Gravis: Clinical Implications and Pathogenesis.Int J Mol Sci2026https://conductscience.org/library/papers/42794580PubMed
42642835Unraveling Neurodegeneration: Common Molecular Mechanisms and Novel Therapeutic Concepts in Major Neurodegenerative Disorders.Brain Behav2026https://conductscience.org/library/papers/42642835PubMed
42382507Coenzyme Q10 Suppression of Cue-related Reinstatement Through Cognition Improvement and Hippocampal Increase in BDNF Expression in Morphine-dependent Male Rats.Basic Clin Neurosci2025https://conductscience.org/library/papers/42382507PubMed
42377452Protective in vitro effects of antioxidants against DNA damage induced by metabolites accumulated in propionic and methylmalonic acidemias.Naunyn Schmiedebergs Arch Pharmacol2026https://conductscience.org/library/papers/42377452PubMed
42249931Effect of six weeks ubiquinol supplementation on mitochondrial respiratory function and exercise capacity in healthy males.Eur J Appl Physiol2026https://conductscience.org/library/papers/42249931PubMed
42158846Recent developments in Friedreich's ataxia: a state-of-the-art review.Brain Commun2026https://conductscience.org/library/papers/42158846PubMed
41868721Integrating Multi-Omics Data to Uncover Causal Links Between Mitochondria-Related Genes and Chronic Obstructive Pulmonary Disease: A Mendelian Randomization Study.Int J Chron Obstruct Pulmon Dis2026https://conductscience.org/library/papers/41868721PubMed
41854937Coenzyme Q10 exerts anti-cancer effects in bladder cancer by inducing ROS-mediated apoptosis and autophagy.J Bioenerg Biomembr2026https://conductscience.org/library/papers/41854937PubMed
41531784Research Progress on Idebenone in Neurodegenerative Diseases.Aging Med (Milton)2025https://conductscience.org/library/papers/41531784PubMed
41483050Programmed cell death pathways in huntington's disease: spotlight on ferroptosis and pyroptosis.Neurol Sci2026https://conductscience.org/library/papers/41483050PubMed
41096911Coenzyme Q10 Ameliorates Chemotherapy-Induced Neurotoxicity in iPSC-Derived Neurons by Reducing Oxidative Stress.Int J Mol Sci2025https://conductscience.org/library/papers/41096911PubMed
41029932Mitochondria as a Therapeutic Target in Metabolic Disorders.Mini Rev Med Chem2026https://conductscience.org/library/papers/41029932PubMed
41017684Mitochondrial DNA homeostasis: A novel therapeutic target for neurodegenerative diseases.Neural Regen Res2026https://conductscience.org/library/papers/41017684PubMed
40874597Therapeutic strategies for Huntington's disease: current approaches and future direction.Neurodegener Dis Manag2026https://conductscience.org/library/papers/40874597PubMed
40253426Coenzyme Q10 microemulsion ion-activated gel: a promising ophthalmic delivery system for enhanced corneal protection and sustained release.BMC Pharmacol Toxicol2025https://conductscience.org/library/papers/40253426PubMed
40097762Nutritional Interventions in Amyotrophic Lateral Sclerosis: From Ketogenic Diet and Neuroprotective Nutrients to the Microbiota-Gut-Brain Axis Regulation.Mol Neurobiol2025https://conductscience.org/library/papers/40097762PubMed
40080152Ameliorative and protective effects of coenzyme Q10 against natural and chemical toxicity: a narrative review.Naunyn Schmiedebergs Arch Pharmacol2025https://conductscience.org/library/papers/40080152PubMed
39994108Low-intensity pulsed ultrasound enhances delivery of 30 nm Q10 for improving mental and memory disorder in APP/PS1 mice.Drug Deliv Transl Res2025https://conductscience.org/library/papers/39994108PubMed
39587666The role of mitochondria in iron overload-induced damage.J Transl Med2024https://conductscience.org/library/papers/39587666PubMed

See all 36 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35199552

GET https://conductscience.org/api/papers/v1/35199552/references?page=2